Zhou L, Zhou Q, Guo Q, Lai P, Rui C, Li W
BMC Cancer. 2025; 25(1):104.
PMID: 39833734
PMC: 11744831.
DOI: 10.1186/s12885-025-13481-w.
Haggenmuller S, Wies C, Abels J, Winterstein J, Heinlein L, Nogueira Garcia C
Nat Commun. 2025; 16(1):789.
PMID: 39824857
PMC: 11742048.
DOI: 10.1038/s41467-025-56160-x.
Qian J, Wan J, Yao Q, Chen Y, Ling T, Zhang Y
Front Pharmacol. 2025; 15():1457226.
PMID: 39776585
PMC: 11703664.
DOI: 10.3389/fphar.2024.1457226.
Karp P, Karp K, Kadziela M, Zajdel R, Zebrowska A
Cancers (Basel). 2025; 16(24.
PMID: 39766163
PMC: 11674410.
DOI: 10.3390/cancers16244264.
Corica D, Bell S, Miller P, Kasperbauer D, Lawler N, Wakefield M
Cancers (Basel). 2024; 16(23).
PMID: 39682188
PMC: 11640241.
DOI: 10.3390/cancers16234002.
Paradigm of biomarkers in metastatic melanoma (Review).
Pekarek L, Sanchez Cedra A, Jaudenes Y, Ospino L, Pedrejon B, Bernier L
Oncol Lett. 2024; 29(2):78.
PMID: 39650232
PMC: 11622106.
DOI: 10.3892/ol.2024.14824.
Cedrus atlantica extract inhibits melanoma progression by suppressing epithelial-mesenchymal transition and inducing mitochondria-mediated apoptosis.
Gao H, Chang K, Huang X, Lee M, Tsai N, Chen T
Med Oncol. 2024; 42(1):22.
PMID: 39643823
DOI: 10.1007/s12032-024-02573-5.
Sex discrepancies in cancer research: a systematic review of prospective and retrospective investigations in lung, melanoma, and colorectal cancers.
Diaz Rosario M, Velez-Morell C, Martinez D
Front Glob Womens Health. 2024; 5:1445139.
PMID: 39588064
PMC: 11586390.
DOI: 10.3389/fgwh.2024.1445139.
Evaluation of Cytotoxic Activity of Cell Biomass from and on Melanoma Cancer Cell.
Hermosaningtyas A, Toton E, Lisiak N, Kruszka D, Budzianowska A, Kikowska M
Molecules. 2024; 29(21).
PMID: 39519799
PMC: 11547748.
DOI: 10.3390/molecules29215158.
Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by Dermatologists.
Witkowski A, Burshtein J, Christopher M, Cockerell C, Correa L, Cotter D
Cancers (Basel). 2024; 16(21.
PMID: 39518033
PMC: 11545296.
DOI: 10.3390/cancers16213592.
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.
Ou Y, Liang S, Gao Q, Shang Y, Liang J, Zhang W
Front Immunol. 2024; 15:1482746.
PMID: 39493767
PMC: 11527641.
DOI: 10.3389/fimmu.2024.1482746.
Parasites revive hope for cancer therapy.
Eissa M, Salem A, El Skhawy N
Eur J Med Res. 2024; 29(1):489.
PMID: 39367471
PMC: 11453045.
DOI: 10.1186/s40001-024-02057-2.
The Impact of the COVID-19 Pandemic on Melanoma Diagnosis: A Single-Center Study.
Sabau A, Cocuz I, Niculescu R, Tinca A, Szoke A, Lazar B
Diagnostics (Basel). 2024; 14(18).
PMID: 39335711
PMC: 11431054.
DOI: 10.3390/diagnostics14182032.
Extract of Araçá-Boi and Its Major Phenolic Compound, Trans-Cinnamic Acid, Reduce Viability and Inhibit Migration of Human Metastatic Melanoma Cells.
Tecchio Borsoi F, da Silva G, Manica D, Bagatini M, Pastore G, Arruda H
Nutrients. 2024; 16(17).
PMID: 39275245
PMC: 11396791.
DOI: 10.3390/nu16172929.
Innate Immune Cells in Melanoma: Implications for Immunotherapy.
Trocchia M, Ventrici A, Modestino L, Cristinziano L, Ferrara A, Palestra F
Int J Mol Sci. 2024; 25(15).
PMID: 39126091
PMC: 11313504.
DOI: 10.3390/ijms25158523.
An overview of benefits and risks of chronic melanocortin-1 receptor activation.
Bohm M, Robert C, Malhotra S, Clement K, Farooqi S
J Eur Acad Dermatol Venereol. 2024; 39(1):39-51.
PMID: 39082868
PMC: 11664455.
DOI: 10.1111/jdv.20269.
Sphingolipid metabolism and regulated cell death in malignant melanoma.
Yan K, Zhang W, Song H, Xu X
Apoptosis. 2024; 29(11-12):1860-1878.
PMID: 39068623
DOI: 10.1007/s10495-024-02002-y.
Marizomib (Salinosporamide A) Promotes Apoptosis in A375 and G361 Melanoma Cancer Cells.
Piskorz W, Kretowski R, Cechowska-Pasko M
Mar Drugs. 2024; 22(7).
PMID: 39057424
PMC: 11278368.
DOI: 10.3390/md22070315.
Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry.
Yang Q, Li Q, Fan H
Arch Dermatol Res. 2024; 316(7):447.
PMID: 38958761
DOI: 10.1007/s00403-024-03020-1.
Exploring the causal relationship between interleukin-6 or C reactive protein and malignant melanoma using a two-sample Mendelian randomization approach.
Wang Q, Zheng W, Pan S
Front Oncol. 2024; 14:1375362.
PMID: 38952546
PMC: 11215064.
DOI: 10.3389/fonc.2024.1375362.